{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T03:02:03Z","timestamp":1777518123845,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"39","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,8]],"date-time":"2016-08-08T00:00:00Z","timestamp":1470614400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000226","name":"Ontario Ministry of Health and Long-Term Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.vaccine.2016.08.020","type":"journal-article","created":{"date-parts":[[2016,8,13]],"date-time":"2016-08-13T04:13:57Z","timestamp":1471061637000},"page":"4678-4683","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Early impact of Ontario\u2019s human papillomavirus (HPV) vaccination program on anogenital warts (AGWs): A population-based assessment"],"prefix":"10.1016","volume":"34","author":[{"given":"Fiona M.","family":"Guerra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura C.","family":"Rosella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheila","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah E.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shelley L.","family":"Deeks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.08.020_b0005","unstructured":"Statistics Canada. Government of Canada, <http:\/\/www.statcan.gc.ca\/tables-tableaux\/sum-som\/l01\/cst01\/demo02a-eng.htm> [accessed February 4, 2016]."},{"key":"10.1016\/j.vaccine.2016.08.020_b0010","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/BF03404066","article-title":"Ontario\u2019s school-based HPV immunization program: school board assent and parental consent","author":"Wilson","year":"2012","journal-title":"Can J Public Health\/Rev Can Sante\u2019e Publique"},{"issue":"7","key":"10.1016\/j.vaccine.2016.08.020_b0015","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1136\/sti.2009.037788","article-title":"Rapid decline in presentations of genital warts after the implementation of a national quadrivalent human papillomavirus vaccination programme for young women","volume":"85","author":"Fairley","year":"2009","journal-title":"Sex Transm Infect"},{"issue":"5","key":"10.1016\/j.vaccine.2016.08.020_b0020","doi-asserted-by":"publisher","first-page":"833","DOI":"10.2105\/AJPH.2011.300465","article-title":"Evidence of human papillomavirus vaccine effectiveness in reducing genital warts: an analysis of California public family planning administrative claims data, 2007\u20132010","volume":"102","author":"Bauer","year":"2012","journal-title":"Am J Public Health"},{"key":"10.1016\/j.vaccine.2016.08.020_b0025","first-page":"jis405","article-title":"Incidence of genital warts in Sweden before and after quadrivalent human papillomavirus vaccine availability","author":"Leval","year":"2012","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2016.08.020_b0030","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1093\/jnci\/djt032","article-title":"Quadrivalent human papillomavirus vaccine effectiveness: a Swedish national cohort study","volume":"105","author":"Leval","year":"2013","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.vaccine.2016.08.020_b0035","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/1471-2334-13-140","article-title":"Decline in in-patient treatments of genital warts among young Australians following the national HPV vaccination program","volume":"13","author":"Ali","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2016.08.020_b0040","first-page":"346","article-title":"Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data","author":"Ali","year":"2013","journal-title":"BMJ, Brit Med J"},{"issue":"2","key":"10.1016\/j.vaccine.2016.08.020_b0045","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/OLQ.0b013e31827bd66b","article-title":"Significant decrease in the incidence of genital warts in young Danish women after implementation of a national human papillomavirus vaccination program","volume":"40","author":"Baandrup","year":"2013","journal-title":"Sex Transm Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2016.08.020_b0050","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.jadohealth.2013.09.018","article-title":"Population impact of HPV vaccines: summary of early evidence","volume":"53","author":"Hariri","year":"2013","journal-title":"J Adolesc Health"},{"issue":"1","key":"10.1016\/j.vaccine.2016.08.020_b0055","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.clinthera.2013.12.005","article-title":"The Australian experience with the human papillomavirus vaccine","volume":"36","author":"Garland","year":"2014","journal-title":"Clin Ther"},{"issue":"1","key":"10.1016\/j.vaccine.2016.08.020_b0060","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s12325-015-0178-4","article-title":"Early direct and indirect impact of quadrivalent HPV (4HPV) vaccine on genital warts: a systematic review","volume":"32","author":"Mariani","year":"2015","journal-title":"Adv Therapy"},{"issue":"5","key":"10.1016\/j.vaccine.2016.08.020_b0065","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S1473-3099(14)71073-4","article-title":"Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis","volume":"15","author":"Drolet","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2016.08.020_b0070","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1097\/OLQ.0b013e3182953ce0","article-title":"Incidence of genital warts in adolescents and young adults in an integrated health care delivery system in the United States before human papillomavirus vaccine recommendations","volume":"40","author":"Camenga","year":"2013","journal-title":"Sex Transm Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2016.08.020_b0075","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/LGT.0b013e31825c3915","article-title":"Temporal trends in genital warts among individuals covered by the public prescription drug insurance plan in the province of Quebec, Canada, from 1998 to 2007","volume":"17","author":"Steben","year":"2013","journal-title":"J Lower Genital Tract Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2016.08.020_b0080","doi-asserted-by":"publisher","first-page":"e009914","DOI":"10.1136\/bmjopen-2015-009914","article-title":"Health service utilization for anogenital warts in Ontario, Canada prior to the human papillomavirus (HPV) vaccine program introduction: a retrospective longitudinal population-based study","volume":"6","author":"Guerra","year":"2016","journal-title":"BMJ Open"},{"issue":"2","key":"10.1016\/j.vaccine.2016.08.020_b0085","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1136\/sti.2008.030999","article-title":"Epidemiology and costs associated with genital warts in Canada","volume":"85","author":"Marra","year":"2009","journal-title":"Sex Transm Infect"},{"issue":"6","key":"10.1016\/j.vaccine.2016.08.020_b0090","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1097\/OLQ.0b013e318198de8c","article-title":"Twenty-year trends in the incidence and prevalence of diagnosed anogenital warts in Canada","volume":"36","author":"Kliewer","year":"2009","journal-title":"Sex Transm Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2016.08.020_b0095","doi-asserted-by":"publisher","first-page":"E74","DOI":"10.1503\/cmaj.140900","article-title":"Effect of human papillomavirus (HPV) vaccination on clinical indicators of sexual behaviour among adolescent girls: the Ontario grade 8 HPV vaccine Cohort study","volume":"187","author":"Smith","year":"2015","journal-title":"Can Med Assoc J"},{"issue":"7","key":"10.1016\/j.vaccine.2016.08.020_b0100","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1097\/MLR.0b013e3181d6886f","article-title":"Low rates of cervical cancer screening among urban immigrants: a population-based study in Ontario","volume":"48","author":"Lofters","year":"2010","journal-title":"Can Med Care"},{"key":"10.1016\/j.vaccine.2016.08.020_b0105","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1071\/SH09145","article-title":"What can surveillance of genital warts tell us?","volume":"7","author":"Fairley","year":"2010","journal-title":"Sex Health"},{"key":"10.1016\/j.vaccine.2016.08.020_b0110","series-title":"Immunization coverage report for school pupils: 2012\u201313 school year","author":"Ontario Agency for Health Protection and Promotion (Public Health Ontario)","year":"2014"},{"key":"10.1016\/j.vaccine.2016.08.020_b0115","unstructured":"Canadian Immunization Committee. Recommendations on a human papillomavirus immunization program. Her Majesty the Queen in Right of Canada, represented by the Minister of Health; 2008. <http:\/\/www.phac-aspc.gc.ca\/publicat\/2008\/papillomavirus-papillome\/papillomavirus-papillome-index-eng.php>."},{"key":"10.1016\/j.vaccine.2016.08.020_b0120","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/BF03404315","article-title":"Older male sexual partner as a marker for sexual risk-taking in adolescent females in Nova Scotia","volume":"1","author":"Langille","year":"2007","journal-title":"Can J Public Health\/Rev Can Sante\u2019e Publique"},{"issue":"4","key":"10.1016\/j.vaccine.2016.08.020_b0125","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1258\/095646204773557802","article-title":"Characteristics of sexual partners and STD infection among American adolescents","volume":"15","author":"Ford","year":"2004","journal-title":"Int J STD AIDS"},{"issue":"5","key":"10.1016\/j.vaccine.2016.08.020_b0130","first-page":"333","article-title":"A perspective on Canadian teenage births, 1992\u201394: older men and younger women?","volume":"88","author":"Millar","year":"1996","journal-title":"Can J Public Health\/Rev Can Sante Publique"},{"issue":"ACS-2","key":"10.1016\/j.vaccine.2016.08.020_b0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14745\/ccdr.v38i00a02a","article-title":"Statement on human papillomavirus vaccine. An Advisory Committee Statement (ACS)","volume":"33","author":"National Advisory Committee on Immunization (NACI)","year":"2007","journal-title":"Can Commun Dis Rep"},{"issue":"5","key":"10.1016\/j.vaccine.2016.08.020_b0140","doi-asserted-by":"publisher","first-page":"e1131","DOI":"10.1542\/peds.2014-2961","article-title":"The early benefits of human papillomavirus vaccination on cervical dysplasia and anogenital warts","volume":"135","author":"Smith","year":"2015","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.vaccine.2016.08.020_b0145","first-page":"53","article-title":"Trends in teen sexual behaviour and condom use","volume":"19","author":"Rotermann","year":"2008","journal-title":"Health Rep"},{"issue":"5","key":"10.1016\/j.vaccine.2016.08.020_b0150","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1542\/peds.2012-1516","article-title":"Sexual activity\u2013related outcomes after human papillomavirus vaccination of 11- to 12-year-olds","volume":"130","author":"Bednarczyk","year":"2012","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.vaccine.2016.08.020_b0155","doi-asserted-by":"publisher","first-page":"e109","DOI":"10.1016\/S1470-2045(14)70053-1","article-title":"HPV vaccinations do not encourage risky sexual behaviour","volume":"15","author":"Tanday","year":"2014","journal-title":"Lancet Oncol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16306776?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16306776?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T04:45:11Z","timestamp":1601009111000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16306776"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":31,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0264410X16306776"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.08.020","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early impact of Ontario\u2019s human papillomavirus (HPV) vaccination program on anogenital warts (AGWs): A population-based assessment","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.08.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2016 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}